Genetic deficiency of indoleamine 2,3-dioxygenase aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model
<p>Nonalcoholic steatohepatitis (NASH) is a chronic liver disease that increases cardiovascular disease risk. Indoleamine 2,3-dioxygenase-1 (IDO1)-mediated tryptophan (Trp) metabolism has been proposed to play an immunomodulatory role in several diseases. The potential of IDO1 to be a link bet...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
MDPI
2022
|
| _version_ | 1797109449004941312 |
|---|---|
| author | Arora, A Tripodi, GL Kareinen, I Berg, M Forteza, MJ Gisterå, A Griepke, S Casagrande, FB Martins, JO Abdalla, DSP Cole, J Monaco, C Ketelhuth, DFJ |
| author_facet | Arora, A Tripodi, GL Kareinen, I Berg, M Forteza, MJ Gisterå, A Griepke, S Casagrande, FB Martins, JO Abdalla, DSP Cole, J Monaco, C Ketelhuth, DFJ |
| author_sort | Arora, A |
| collection | OXFORD |
| description | <p>Nonalcoholic steatohepatitis (NASH) is a chronic liver disease that increases cardiovascular disease risk. Indoleamine 2,3-dioxygenase-1 (IDO1)-mediated tryptophan (Trp) metabolism has been proposed to play an immunomodulatory role in several diseases. The potential of IDO1 to be a link between NASH and cardiovascular disease has never been investigated. Using Apoe<sup>−/−</sup> and Apoe<sup>−/−</sup>Ido1<sup>−/−</sup> mice that were fed a high-fat, high-cholesterol diet (HFCD) to simultaneously induce NASH and atherosclerosis, we found that Ido1 deficiency significantly accelerated atherosclerosis after 7 weeks. Surprisingly, Apoe<sup>−/−</sup>Ido1<sup>−/−</sup> mice did not present a more aggressive NASH phenotype, including hepatic lipid deposition, release of liver enzymes, and histopathological parameters. As expected, a lower L-kynurenine/Trp (Kyn/Trp) ratio was found in the plasma and arteries of Apoe<sup>−/−</sup>Ido1<sup>−/−</sup> mice compared to controls. However, no difference in the hepatic Kyn/Trp ratio was found between the groups. Hepatic transcript analyses revealed that HFCD induced a temporal increase in tryptophan 2,3-dioxygenase (Tdo2) mRNA, indicating an alternative manner to maintain Trp degradation during NASH development in both Apoe<sup>−/−</sup> and Apoe<sup>−/−</sup>Ido1<sup>−/</sup>mice<sup>−</sup>. Using HepG2 hepatoma cell and THP1 macrophage cultures, we found that iron, TDO2, and Trp degradation may act as important mediators of cross-communication between hepatocytes and macrophages regulating liver inflammation. In conclusion, we show that Ido1 deficiency aggravates atherosclerosis, but not liver disease, in a newly established NASH and atherosclerosis comorbidity model. Our data indicate that the overexpression of TDO2 is an important mechanism that helps in balancing the kynurenine pathway and inflammation in the liver, but not in the artery wall, which likely determined disease outcome in these two target tissues.</p> |
| first_indexed | 2024-03-07T07:40:32Z |
| format | Journal article |
| id | oxford-uuid:2c264c79-70ca-4285-bad4-cb1611e5cf9c |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:40:32Z |
| publishDate | 2022 |
| publisher | MDPI |
| record_format | dspace |
| spelling | oxford-uuid:2c264c79-70ca-4285-bad4-cb1611e5cf9c2023-04-28T13:33:32ZGenetic deficiency of indoleamine 2,3-dioxygenase aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity modelJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:2c264c79-70ca-4285-bad4-cb1611e5cf9cEnglishSymplectic ElementsMDPI2022Arora, ATripodi, GLKareinen, IBerg, MForteza, MJGisterå, AGriepke, SCasagrande, FBMartins, JOAbdalla, DSPCole, JMonaco, CKetelhuth, DFJ<p>Nonalcoholic steatohepatitis (NASH) is a chronic liver disease that increases cardiovascular disease risk. Indoleamine 2,3-dioxygenase-1 (IDO1)-mediated tryptophan (Trp) metabolism has been proposed to play an immunomodulatory role in several diseases. The potential of IDO1 to be a link between NASH and cardiovascular disease has never been investigated. Using Apoe<sup>−/−</sup> and Apoe<sup>−/−</sup>Ido1<sup>−/−</sup> mice that were fed a high-fat, high-cholesterol diet (HFCD) to simultaneously induce NASH and atherosclerosis, we found that Ido1 deficiency significantly accelerated atherosclerosis after 7 weeks. Surprisingly, Apoe<sup>−/−</sup>Ido1<sup>−/−</sup> mice did not present a more aggressive NASH phenotype, including hepatic lipid deposition, release of liver enzymes, and histopathological parameters. As expected, a lower L-kynurenine/Trp (Kyn/Trp) ratio was found in the plasma and arteries of Apoe<sup>−/−</sup>Ido1<sup>−/−</sup> mice compared to controls. However, no difference in the hepatic Kyn/Trp ratio was found between the groups. Hepatic transcript analyses revealed that HFCD induced a temporal increase in tryptophan 2,3-dioxygenase (Tdo2) mRNA, indicating an alternative manner to maintain Trp degradation during NASH development in both Apoe<sup>−/−</sup> and Apoe<sup>−/−</sup>Ido1<sup>−/</sup>mice<sup>−</sup>. Using HepG2 hepatoma cell and THP1 macrophage cultures, we found that iron, TDO2, and Trp degradation may act as important mediators of cross-communication between hepatocytes and macrophages regulating liver inflammation. In conclusion, we show that Ido1 deficiency aggravates atherosclerosis, but not liver disease, in a newly established NASH and atherosclerosis comorbidity model. Our data indicate that the overexpression of TDO2 is an important mechanism that helps in balancing the kynurenine pathway and inflammation in the liver, but not in the artery wall, which likely determined disease outcome in these two target tissues.</p> |
| spellingShingle | Arora, A Tripodi, GL Kareinen, I Berg, M Forteza, MJ Gisterå, A Griepke, S Casagrande, FB Martins, JO Abdalla, DSP Cole, J Monaco, C Ketelhuth, DFJ Genetic deficiency of indoleamine 2,3-dioxygenase aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model |
| title | Genetic deficiency of indoleamine 2,3-dioxygenase aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model |
| title_full | Genetic deficiency of indoleamine 2,3-dioxygenase aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model |
| title_fullStr | Genetic deficiency of indoleamine 2,3-dioxygenase aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model |
| title_full_unstemmed | Genetic deficiency of indoleamine 2,3-dioxygenase aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model |
| title_short | Genetic deficiency of indoleamine 2,3-dioxygenase aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model |
| title_sort | genetic deficiency of indoleamine 2 3 dioxygenase aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model |
| work_keys_str_mv | AT aroraa geneticdeficiencyofindoleamine23dioxygenaseaggravatesvascularbutnotliverdiseaseinanonalcoholicsteatohepatitisandatherosclerosiscomorbiditymodel AT tripodigl geneticdeficiencyofindoleamine23dioxygenaseaggravatesvascularbutnotliverdiseaseinanonalcoholicsteatohepatitisandatherosclerosiscomorbiditymodel AT kareineni geneticdeficiencyofindoleamine23dioxygenaseaggravatesvascularbutnotliverdiseaseinanonalcoholicsteatohepatitisandatherosclerosiscomorbiditymodel AT bergm geneticdeficiencyofindoleamine23dioxygenaseaggravatesvascularbutnotliverdiseaseinanonalcoholicsteatohepatitisandatherosclerosiscomorbiditymodel AT fortezamj geneticdeficiencyofindoleamine23dioxygenaseaggravatesvascularbutnotliverdiseaseinanonalcoholicsteatohepatitisandatherosclerosiscomorbiditymodel AT gisteraa geneticdeficiencyofindoleamine23dioxygenaseaggravatesvascularbutnotliverdiseaseinanonalcoholicsteatohepatitisandatherosclerosiscomorbiditymodel AT griepkes geneticdeficiencyofindoleamine23dioxygenaseaggravatesvascularbutnotliverdiseaseinanonalcoholicsteatohepatitisandatherosclerosiscomorbiditymodel AT casagrandefb geneticdeficiencyofindoleamine23dioxygenaseaggravatesvascularbutnotliverdiseaseinanonalcoholicsteatohepatitisandatherosclerosiscomorbiditymodel AT martinsjo geneticdeficiencyofindoleamine23dioxygenaseaggravatesvascularbutnotliverdiseaseinanonalcoholicsteatohepatitisandatherosclerosiscomorbiditymodel AT abdalladsp geneticdeficiencyofindoleamine23dioxygenaseaggravatesvascularbutnotliverdiseaseinanonalcoholicsteatohepatitisandatherosclerosiscomorbiditymodel AT colej geneticdeficiencyofindoleamine23dioxygenaseaggravatesvascularbutnotliverdiseaseinanonalcoholicsteatohepatitisandatherosclerosiscomorbiditymodel AT monacoc geneticdeficiencyofindoleamine23dioxygenaseaggravatesvascularbutnotliverdiseaseinanonalcoholicsteatohepatitisandatherosclerosiscomorbiditymodel AT ketelhuthdfj geneticdeficiencyofindoleamine23dioxygenaseaggravatesvascularbutnotliverdiseaseinanonalcoholicsteatohepatitisandatherosclerosiscomorbiditymodel |